216762 Seminar

WiSe 21/22: The Drug Discovery Process in the Pharmaceutical Industry - From target to hit identification

Roman Hillig, Holger Steuber

Information for students

Vertonte ppt und/oder Videokonferenz zur regulären Zeit. Die Teile (I im SS und II im WS) können in beliebiger Reihenfolge besucht werden, sie sind nicht aufbauend.

Additional information / Pre-requisites

Seminars 216761 and 216762 can be attended in arbitrary sequence, they do not build-up on each other.


1. Target Identification and Hit Finding
2. X-ray Crystallography in DD
3. Molecular Modeling
4. Fragment-Based Drug Design
5. New Modalities, New target Classes
6. Target Class: Ras GTPase superfamily
7. Target Class: Epigenetic Targets
8. Nuclear Magnetic Resonance

Dr. R. Hillig: roman.hillig@nuvisan.com
Dr. H. Steuber: holger.steuber@ nuvisan.com close

Subjects A - Z